Symbol: CSE: IZO
Market Cap: Private
- Izotropic is an advanced MedTech company commercializing a next-generation diagnostic breast imaging platform to replace traditional mammography using 3D CT (three dimensional computed tomography) for more accurate breast cancer detection and diagnosis.
- We have a pioneering team of internationally recognized professionals in place that have literally helped establish the current standards of breast cancer diagnostic care, along with leading US hospitals and medical center affiliates in place. CEO Dr. John McGraw has a strong track record as business developer and innovator with many sizable investment exits under his belt.
- Considering capital raising options to help accelerate testing and optimization of the device as the Company prepares for its upcoming clinical study and submission for market authorization in the U.S.